EGFR mutation (EGFRm) prevalence and mortality in patients with stage IB-IIIA NSCLC: A cohort study in Denmark

Research output: Contribution to journal › Conference abstract in journal › Research › peer-review

Original language	English
Journal	Journal of Thoracic Oncology
Volume	16
Issue number	4, Suppl.
Pages (from-to)	S730-S731
ISSN	1556-0864
DOIs	https://doi.org/10.1016/S1556-0864(21)01907-9
Publication status	Published - Apr 2021
Event	European Lung Cancer Virtual Congress - Virtual Duration: 25. Mar 2021 → 27. Mar 2021

Conference	European Lung Cancer Virtual Congress
Location	Virtual
Period	25/03/2021 → 27/03/2021

Documents & Links

@article{8378ba005363407994437748fb713087,

title = "EGFR mutation (EGFRm) prevalence and mortality in patients with stage IB-IIIA NSCLC: A cohort study in Denmark",

author = "E. Jakobsen and A. Taylor and V. Ehrenstein",

year = "2021",

month = apr,

doi = "10.1016/S1556-0864(21)01907-9",

language = "English",

volume = "16",

pages = "S730--S731",

journal = "Journal of Thoracic Oncology",

issn = "1556-0864",

publisher = "Elsevier",

number = "4, Suppl.",

note = "European Lung Cancer Virtual Congress, ELCC 2021 ; Conference date: 25-03-2021 Through 27-03-2021",

}

TY - ABST

T1 - EGFR mutation (EGFRm) prevalence and mortality in patients with stage IB-IIIA NSCLC: A cohort study in Denmark

AU - Jakobsen, E.

AU - Taylor, A.

AU - Ehrenstein, V.

PY - 2021/4

Y1 - 2021/4

U2 - 10.1016/S1556-0864(21)01907-9

DO - 10.1016/S1556-0864(21)01907-9

M3 - Conference abstract in journal

SN - 1556-0864

VL - 16

SP - S730-S731

JO - Journal of Thoracic Oncology

JF - Journal of Thoracic Oncology

IS - 4, Suppl.

T2 - European Lung Cancer Virtual Congress

Y2 - 25 March 2021 through 27 March 2021

ER -